[1]王中京 邓艾平 李居怡 徐子辉 吕晓玉 张旭艳 付秀丽 李亚蓉 宋春宇.细胞因子与糖尿病足血管发生的相关性研究[J].国际内分泌代谢杂志,2019,39(02):120-139.[doi:10.3760/cma.j.issn.1673-4157.2019.02.012]
 Wang Zhongjing,Deng Aiping,Li Juyi,et al.Study on the correlation of cytokines and the angiogenesis of diabetic foot[J].International Journal of Endocrinology and Metabolism,2019,39(02):120-139.[doi:10.3760/cma.j.issn.1673-4157.2019.02.012]
点击复制

细胞因子与糖尿病足血管发生的相关性研究()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
39
期数:
2019年02期
页码:
120-139
栏目:
综述
出版日期:
2019-03-20

文章信息/Info

Title:
Study on the correlation of cytokines and the angiogenesis of diabetic foot
作者:
王中京 邓艾平 李居怡 徐子辉 吕晓玉 张旭艳 付秀丽 李亚蓉 宋春宇
华中科技大学同济医学院附属武汉中心医院 430014
Author(s):
Wang Zhongjing Deng Aiping Li Juyi Xu Zihui Lyu Xiaoyu Zhang Xuyan Fu Xiuli Li Yarong Song Chunyu
The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China
关键词:
糖尿病足 细胞因子 血管发生
Keywords:
Diabetic foot Cytokine Angiogenesis
DOI:
10.3760/cma.j.issn.1673-4157.2019.02.012
摘要:
近些年来,基于细胞因子促进糖尿病足患者足部血管新生的疗法引起了人们的关注,而血管新生促进因子和抑制因子之间的动态平衡是维持伤口愈合正常发生的关键。通过介绍促血管生成细胞因子(血管内皮生长因子、低氧诱导因子-1、成纤维细胞生长因子、血小板衍生生长因子等)和抑血管生成细胞因子(色素上皮衍生因子和激肽释放酶结合蛋白)的作用机制,旨在为细胞因子治疗糖尿病足提供新的可行性方案。
Abstract:
In recent years, cytokine-based therapy for diabetic foot has attracted much attention, and the dynamic balance between angiogenesis-promoting factors and inhibitors was the key to maintain the normal occurrence of wound healing. Mechanism of cytokines of angiogenesis-promoting(vascular endothelial growth factor, hypoxia-inducible factor-1, fibroblast growth factor, platelet-derived growth factor, et al.)and inhibitors(pigment epithelium derived factor and kallikrein binding protein )were expounded. The aim was to provide a new protocol for the treatment of diabetic foot with cytokines.

参考文献/References:

[1] Kolossváry E,Bánsághi Z,Szabó GV,et al.Ischemic origin of diabetic foot disease. Epidemiology, difficulties of diagnosis, options for prevention and revascularization[J].Orv Hetil,2017,158(6):203-211.DOI:10.1556/650.2017.30649.
[2] Markakis K,Bowling FL,Boulton AJ.The diabetic foot in 2015: an overview[J].Diabetes Metab Res Rev,2016,32(Suppl 1):169-178.DOI:10.1002/dmrr.2740.
[3] Eming SA,Martin P,Tomic-Canic M.Wound repair and regeneration: mechanisms, signaling, and translation[J].Sci Transl Med,2014,6(265):265sr6.DOI:10.1126/scitranslmed.3009337.
[4] 徐波, 杨彩哲, 吴石白, 等. 糖尿病足患者截肢相关危险因素分析[J]. 中华内科杂志, 2017, 56(1):24-28. DOI: 10.3760/cma.j.issn.0578-1426.2017.01.007.
[5] 崔国胜, 曾剑玉, 张婧, 等. 神经生长因子对2型糖尿病小鼠骨髓基质细胞体外成骨能力的影响[J]. 中华口腔医学杂志, 2018, 53(2):97-102. DOI: 10.3760/cma.j.issn.1002-0098.2018.02.005.
[6] Andreakos ET,Foxwell BM,Brennan FM,et al.Cytokines and anti-cytokine biologicals in autoimmunity: present and future[J].Cytokine Growth Factor Rev,2002,13(4-5):299-313.
[7] Bodnar RJ.Chemokine regulation of angiogenesis during wound healing[J].Adv Wound Care(New Rochelle),2015,4(11):641-650.DOI:10.1089/wound.2014.0594.
[8] Coppinger JA,Cagney G,Toomey S,et al.Characterization of the proteins released from activated platelets leads to localization of novelplatelet proteins in human atherosclerotic lesions[J].Blood,2004,103(6):2096-2104.DOI:10.1182/blood-2003-08-2804.
[9] Bauer SM,Bauer RJ,Velazquez OC.Angiogenesis, vasculogenesis, and induction of healing in chronic wounds[J].Vasc Endovascular Surg,2005,39(4):293-306. DOI:10.1177/153857440503900401.
[10] Liang X,Xu F,Li X,et al.VEGF signal system: the application of antiangiogenesis[J].Curr Med Chem,2014,21(7):894-910.
[11] Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration[J]. Diabetes, 2012, 61(11):2937-2947. DOI: 10.2337/db12-0227.
[12] Mohajeri-Tehrani MR,Nasiripoor F,Torkaman G,et al.Effect of low-intensity direct current on expression of vascular endothelial growth factor and nitric oxide in diabetic foot ulcers[J].J Rehabil Res Dev,2014,51(5):815-824.
[13] Amoli MM,Hasani-Ranjbar S,Roohipour N,et al.VEGF gene polymorphism association with diabetic foot ulcer[J].Diabetes Res Clin Pract,2011,93(2):215-219.DOI:10.1016/j.diabres.2011.04.016.
[14] Deshpande MS,Kuchroo PV.A novel dermal tissue construct: development and in vitro characterization[J].Biotechnol Prog,2010,26(5):1424-1430.DOI:10.1002/btpr.458.
[15] Semenza GL.Hypoxia-inducible factors in physiology and medicine[J].Cell,2012,148(3):399-408. DOI:10.1016/j.cell.2012.01.021.
[16] Semenza GL.Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology[J].Annu Rev Pathol,2014,9:47-71.DOI:10.1146/annurev-pathol-012513-104720.
[17] 陈明卫,李燕萍,唐益忠,等.不同来源和移植途径的自体干细胞治疗糖尿病缺血性下肢血管病变的随机对照研究[J].中华临床医师杂志(电子版),2013,26(14):6418-6423.DOI: 10.3969/cma.j.issn.1674-0785.2013.14.048.
[18] Catrina SB,Zheng X.Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers[J].Diabetes Metab Res Rev,2016,32(Suppl 1):179-185.DOI:10.1002/dmrr.2742.
[19] Thangarajah H,Vial IN,Grogan RH,et al.HIF-1alpha dysfunction in diabetes[J].Cell Cycle,2010,9(1):75-79.DOI: 10.4161/cc.9.1.10371.
[20] Ornitz DM,Itoh N.The fibroblast growth factor signaling pathway[J].Wiley Interdiscip Rev Dev Biol,2015,4(3):215-266. DOI:10.1002/wdev.176.
[21] Mizia-Malarz A,Sobol G,Wo H.Proangiogenic factors: vascular-endothelial growth factor(VEGF)and basic fibroblast growth factor--the characteristics and function[J].Przegl Lek,2008,65(7-8):353-357.
[22] Qazi Y,Maddula S,Ambati BK.Mediators of ocular angiogenesis[J].J Genet,2009,88(4):495-515.
[23] Kulwas A,Drela E,Jundzi W,et al.Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications[J].J Diabetes Complications,2015,29(5):686-690.DOI:10.1016/j.jdiacomp.2015.03.013.
[24] Fredriksson L,Li H,Eriksson U.The PDGF family: four gene products form five dimeric isoforms[J].Cytokine Growth Factor Rev,2004,15(4):197-204. DOI:10.1016/j.cytogfr.2004.03.007.
[25] Drela E,Kulwas A,Jundzi W,et al.VEGF-A and PDGF-BB--angiogenic factors and the stage of diabetic foot syndrome advancement[J].Endokrynol Pol,2014,65(4):306-312.DOI:10.5603/EP.2014.0042.
[26] Moriya J,Wu X,Zavala-Solorio J,et al.Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice[J].J Vasc Surg,2014,59(5):1402-1409.e1-4.DOI:10.1016/j.jvs.2013.04.053.
[27] Li H,Fu X,Zhang L,et al.Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics[J].J Surg Res,2008,145(1):41-48.DOI: 10.1016/j.jss.2007.02.044.
[28] Graiani G,Emanueli C,Desortes E,et al.Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice[J].Diabetologia,2004,47(6):1047-1054.DOI:10.1007/s00125-004-1414-7.
[29] Galkowska H,Wojewodzka U,Olszewski WL.Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers[J].Wound Repair Regen,2006,14(5):558-565.DOI: 10.1111/j.1743-6109.2006.00155.x.
[30] Jenkins AJ,Fu D,Azar M,et al.Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients[J].J Diabetes Complications,2014,28(3):353-359.DOI:10.1016/j.jdiacomp.2014.01.008.
[31] Choi KM,Hwang SY,Hong HC,et al.C1q/TNF-related protein-3(CTRP-3)and pigment epithelium-derived factor(PEDF)concentrations in patients with type 2 diabetes and metabolic syndrome[J].Diabetes,2012,61(11):2932-2936. DOI:10.2337/db12-0217.
[32] Qi W,Yang C,Dai Z,et al.High levels of pigment epithelium-derived factor in diabetes impair wound healing through suppression of Wnt signaling[J].Diabetes,2015,64(4):1407-1419. DOI:10.2337/db14-1111.
[33] Chao J,Bledsoe G,Chao L.Protective role of kallistatin in vascular and organ injury[J].Hypertension,2016,68(3):533-541.DOI:10.1161/HYPERTENSIONAHA.116.07861.
[34] McBride JD,Jenkins AJ,Liu X,et al.Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling[J].J Invest Dermatol,2014,134(6):1725-1734.DOI:10.1038/jid.2014.40.
[35] Bhansali A,Venkatesh S,Dutta P,et al.Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast[J].Diabetes Res Clin Pract,2009,83(1):e13-e16. DOI:10.1016/j.diabres.2008.10.005.

相似文献/References:

[1]褚月颉,王鹏华,李代清,等.糖尿病足患者创面肉芽组织中Angiomotin表达的探讨[J].国际内分泌代谢杂志,2015,(04):226.[doi:10.3760/cma.j.issn.1673-4157.2015.04.003]
 Chu Yuejie*,Wang Penghua,Li Daiqing,et al.Angiomotin expression in wound granulation tissues from patients with diabetic foot[J].International Journal of Endocrinology and Metabolism,2015,(02):226.[doi:10.3760/cma.j.issn.1673-4157.2015.04.003]
[2]惠宗光,周学伟,李文通,等.β3肾上腺素能受体基因多态性与糖尿病足的相关性研究[J].国际内分泌代谢杂志,2014,(02):138.[doi:10.3760/cma.j.issn.1673-4157.2014.02.019]
 Hui Zongguang*,Zhou Xuewei,Li Wentong,et al.Relationship between gene polymorphism of beta 3-adrenergic receptor and diabetic foot[J].International Journal of Endocrinology and Metabolism,2014,(02):138.[doi:10.3760/cma.j.issn.1673-4157.2014.02.019]
[3]郑仁东 刘超.炎性反应与甲状腺肿瘤[J].国际内分泌代谢杂志,2015,(06):417.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.015]
 Zheng Rendong,Liu Chao.Inflammation and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2015,(02):417.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.015]
[4]郭志芹,韩学尧,沈景红.高压氧治疗糖尿病足溃疡的研究进展[J].国际内分泌代谢杂志,2017,37(02):108.[doi:10.3760/cma.j.issn.1673-4157.2017.02.010]
 Guo Zhiqin*,Han Xueyao,Shen Jinghong..Hyperbaric oxygen therapy for diabetic foot ulcers[J].International Journal of Endocrinology and Metabolism,2017,37(02):108.[doi:10.3760/cma.j.issn.1673-4157.2017.02.010]
[5]王丙玉 孙建平 段薇.Th1、Th2、Th17相关细胞因子在甲状腺相关眼病中的 作用机制[J].国际内分泌代谢杂志,2018,38(06):394.[doi:10.3760/cma.j.issn.1673-4157.2018.06.008]
 Wang Bingyu,Sun Jianping,Duan Wei.Mechanism of Th1, Th2, Th17 related cytokines in thyroid-associated ophthalmopathy[J].International Journal of Endocrinology and Metabolism,2018,38(02):394.[doi:10.3760/cma.j.issn.1673-4157.2018.06.008]
[6]杜苏苏,李晓南.姜黄素对非酒精性脂肪性肝病的调控作用[J].国际内分泌代谢杂志,2020,40(06):399.[doi:10.3760/cma.j.cn121383-20200117-01026]
 Du Susu,Li Xiaonan.Regulatory effects of curcumin on nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2020,40(02):399.[doi:10.3760/cma.j.cn121383-20200117-01026]
[7]徐俊,许樟荣.国际糖尿病足工作组《糖尿病足感染诊断与治疗指南 (2019版)》解读[J].国际内分泌代谢杂志,2020,40(06):425.[doi:10.3760/cma.j.cn121383-20200710-07077]
 Xu Jun,Xu Zhangrong.Interpretation of diagnosis and treatment guidelines for diabetic foot infection(2019 Edition)by international Working Group on Diabetic Foot[J].International Journal of Endocrinology and Metabolism,2020,40(02):425.[doi:10.3760/cma.j.cn121383-20200710-07077]
[8]徐俊,许樟荣.国际糖尿病足工作组《糖尿病足溃疡周围动脉病变诊断、预后与管理指南(2019版)》解读[J].国际内分泌代谢杂志,2021,41(02):142.[doi:10.3760/cma.j.cn121383-20210109-01022]
 Xu Jun,Xu Zhangrong..Interpretation of guideline on diagnosis, prognosis and management of peripheral artery disease in patients with a foot ulcer and diabetes(2019 edition)by International Working Group on the Diabetic Foot[J].International Journal of Endocrinology and Metabolism,2021,41(02):142.[doi:10.3760/cma.j.cn121383-20210109-01022]

备注/Memo

备注/Memo:
通信作者:邓艾平,Email:doctorwangzj@163.com
基金项目:湖北省卫生计生委科研基金面上项目(WJ2017M183)
Corresponding author: Deng Aiping, Email: doctorwangzj@163.com
Fund program:Foundation of Health and Family Planning Commission of Hubei Province(WJ2017M183)
更新日期/Last Update: 2019-03-20